Targeting the Cell Cycle Checkpoints CHK1 and CHK2 is a Novel Therapeutic Approach for Pediatric Neuroblastoma

被引：0
|
作者：
Morrison, Ben [1 ]
Chilamakuri, Rameswari [1 ]
Agarwal, Saurabh
机构：
[1] St Johns Univ, Jamaica, NY 11439 USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.230730
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
49
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeted gene repair activates Chk1 and Chk2 and stalls replication in corrected cells
    Ferrara, L
    Kmiec, EB
    DNA REPAIR, 2006, 5 (04) : 422 - 431
  • [22] Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites
    S G Durkin
    M F Arlt
    N G Howlett
    T W Glover
    Oncogene, 2006, 25 : 4381 - 4388
  • [23] The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia
    di Rora, Andrea Ghelli Luserna
    Iacobucci, Ilaria
    Imbrogno, Enrica
    Derenzini, Enrico
    Ferrari, Anna
    Robustelli, Valentina
    Guadagnuolo, Viviana
    Papayannidis, Cristina
    Abbenante, Maria Chiara
    Grilli, Sandro
    Martinelli, Giovanni
    CANCER RESEARCH, 2016, 76
  • [24] CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses
    Yan, T
    Desai, AB
    Jacobberger, JW
    Sramkoski, RM
    Loh, T
    Kinsella, TJ
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (09) : 1147 - 1157
  • [25] Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites
    Durkin, S. G.
    Arlt, M. F.
    Howlett, N. G.
    Glover, T. W.
    ONCOGENE, 2006, 25 (32) : 4381 - 4388
  • [26] Cross-talk between Chk1 and Chk2 in double-mutant thymocytes
    Zaugg, Kathrin
    Su, Yu-Wen
    Reilly, Patrick T.
    Moolani, Yasmin
    Cheung, Carol C.
    Hakem, Razquallah
    Hirao, Atsushi
    Elledge, Stephen J.
    Mak, Tak W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (10) : 3805 - 3810
  • [27] Chk1-S is a ubiquitously expressed splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints
    Pabla, N. S.
    Bhatt, K.
    Dong, Z.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [28] Mutational analysis of Chk1, Chk2, Apaf1 and Rb1 in human malignant melanoma cell lines
    Papp, Thilo
    Niemetz, Annett
    Dosdahl, Nils
    Kumar, Krishan
    Schiffmann, Dietmar
    ONCOLOGY REPORTS, 2007, 17 (01) : 135 - 140
  • [29] Utilization of peptide libraries to determine substrate motifs for human Chk1 and hCds1/Chk2
    Rathbun, G
    Giarratani, L
    O'Neill, T
    FASEB JOURNAL, 2002, 16 (05): : A1242 - A1242
  • [30] p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome:: Further evidence of CHK2 in inherited cancer predisposition
    Vahteristo, P
    Tamminen, A
    Karvinen, P
    Eerola, H
    Eklund, C
    Aaltonen, LA
    Blomqvist, C
    Aittomäki, K
    Nevanlinna, H
    CANCER RESEARCH, 2001, 61 (15) : 5718 - 5722
12345